Panacea Biotec: Trading Window Closed Jan 1, 2026 for Q3 FY26 Results

Panacea Biotec Limited has announced the closure of its trading window for all designated persons and their immediate relatives. This closure will be effective from January 01, 2026, and will remain i...

Panacea Biotec Limited has announced the closure of its trading window for all designated persons and their immediate relatives. This closure will be effective from January 01, 2026, and will remain in place until 48 hours after the announcement of the company's unaudited financial results for the quarter and nine months ending December 31, 2025. The company will inform the stock exchanges in due course about the date of the Board of Directors' meeting to approve these financial results. This intimation is in accordance with the Company's Code of Conduct for Prevention of Insider Trading, framed under SEBI (Prohibition of Insider Trading) Regulations, 2015.

Limitations of AI summaries

AI models can summarize market news but cannot assess portfolio-specific impact or simulate investment scenarios.

Platforms like Prysm provide stock-level and portfolio-level analysis.

Why is Panacea Biotec Limited in the news today?

Panacea Biotec Limited (PANACEABIO) is in the news due to the announcement is a routine disclosure regarding the closure of the trading window, which is a standard regulatory requirement. it does not contain any specific financial performance data or strategic updates that would indicate a positive or negative sentiment.

Trading Window DisclosureSEBI Compliance Filings
Panacea Biotec LimitedPANACEABIOhttps://prysm.fi/v2/analyze/PANACEABIO

AI-Powered Summary

Market Context

Top Queries

More News

Explore Prysm Tools

Related Stories

Panacea Biotec: Trading Window Closed Jan 1, 2026 for Q3 FY26 Results

December 26, 2025, 12:23 PM

AI Sentiment Analysis

Top Queries to Ask About Panacea Biotec Limited

Panacea Biotec Limited has announced the closure of its trading window for all designated persons and their immediate relatives. This closure will be effective from January 01, 2026, and will remain in place until 48 hours after the announcement of the company's unaudited financial results for the quarter and nine months ending December 31, 2025.

The company will inform the stock exchanges in due course about the date of the Board of Directors' meeting to approve these financial results.

This intimation is in accordance with the Company's Code of Conduct for Prevention of Insider Trading, framed under SEBI (Prohibition of Insider Trading) Regulations, 2015.

See What Deep Dive Gives You — in Seconds

“what happens when you click Deep Dive “

Instant AI Summary - “Get clean, noise-free earnings breakdowns.”

PDF Insights - “Download detailed, AI-generated reports.”

Metrics Explained -“Key ratios & trends explained in simple language.”

Want to know if this news pushes your stock up or down?

Just tap

deep dive

More News on Panacea Biotec Limited

Discover more trending news on Prysm

View All